AP-811

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAP-811
Drug Alias NameNPRC agonist (Santen Pharmaceutical)AP-811
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNatriuretic peptide receptor 3 agonists
TargetsNatriuretic peptide receptor 3
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanten Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanten Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A